Global CAR-T Therapy Global Market Report 2024

CAR-T Therapy Global Market Report 2023 – By Type (Monotherapy, Combination Therapy), By Target Antigen (CD19, CD22, Other Target Antigens), By Application (Acute Lymphoblastic Leukemia, Diffuse Large BCell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : May 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
CAR-T Therapy Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

The chimeric antigen receptor -T therapy is a type of immunotherapy in which T-cells are taken from the patient’s blood are modified in a laboratory with the addition of a special protein receptor that grants T-cells the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. This special protein receptor, known as the chimeric antigen receptor (CAR), attaches to a specific protein on a patient’s cancer cells. The infused cells multiply and prevail in the patient’s body as living drugs.

The main types of chimeric antigen receptor -T therapy is monotherapy and combination therapy. Monotherapy is used in the treatment of any disease with a single drug. The target antigens involved are CD19, CD22, and others that are used in various applications such as acute lymphoblastic leukemia, diffuse large b-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, multiple myeloma, and others.

The global CAR-T therapy pipeline analysis market is segmented -

1) By Type: Monotherapy, Combination Therapy

2) By Target Antigen: CD19, CD22, Other Target Antigens

3) By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications

The global car-t therapy pipeline analysis market size grew from $1.8 billion in 2022 to $2.25 billion in 2023 at a compound annual growth rate (CAGR) of 25.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global car-t therapy pipeline analysis is expected to grow from $3.9 billion in 2027 at a CAGR of 14.7%.

The CAR-T therapy market is driven by the increasing financial support provided by different organizations to promote the development and consumption of CAR-T therapy. The government and non-government organizations provide financial support to the companies in the CAR-T therapy market for research and development and the patients for their treatment of acute lymphoblastic leukemia (ALL). For instance, in December 2021, the University of California San Diego School of Medicine (CA, USA) was granted a funding of US$ 4.1 million for the development of novel chimeric antigen receptor (CAR-T) cell therapy. The grant was awarded by California Institute for Regenerative Medicine (CIRM; CA, USA)?governing board.The financial support provided by different organizations towards CAR-T therapy positively drives the growth of the CAR-T therapy market.

Major players in the chimeric antigen receptor -T therapy market report are Novartis AG, Kite Pharma, Pfizer Inc., Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Mustang Bio, and Immune Therapeutics.

The limitations on the application of CAR-T therapy limit the growth of the market. The limitations of CAR-T therapy include its failure to treat other types of cancer, side effects, and the high cost of treatment. CAR-T therapy is widely used as a treatment for a particular type of blood cancer and fails to treat other types of cancers such as lung cancer or breast cancer. Further, in many cases, the application of CAR-T therapy results in cytokine release syndrome (CRS). CRS is a severe flu-like condition causing high fever, nausea, chills, headache, rash, and troubled breathing. Further, the high cost limits the growth of the market. According to a report from Kaiser Health News, the per-patient cost of CAR-T cell therapy was more than $1 million in 2021. Thus, the growth of CAR-T therapy is restricted by the various limitations on the application of CAR-T therapy.

The companies in the CAR-T therapy market are conducting clinical trials to assess the ability of CAR-T therapy to treat multiple myeloma. Multiple myeloma is a type of white blood cell cancer where the cancer cells accumulate in the bone marrow and surrounds the healthy blood cells. CAR-T therapy is being tested as a treatment for multiple myeloma. CAR-T cells are modified to target the multiple myeloma causing cells to treat the relapsed or refractory multiple myeloma (RRMM). For instance, in December 2021, Novartis announced the introduction of T-Charge™, the company’s next-generation CAR-T platform that will serve as the foundation for various new investigational CAR-T cell therapies in the Novartis pipeline. The product was in the early clinical stage (Phase I).

In January 2020, Astellas Pharma, a Japan-based pharmaceuticals company acquired Xyphos for $120m(€107m). The acquisition would add five pre-clinical candidates to Astellas Pharma’s portfolio. Xyphos is a US-based CAR-T cell therapy developer.

North America was the largest region in the CAR-t therapy market in 2022. Western Europe was the second-largest region in the global CAR-T therapy market share. The regions covered in the chimeric antigen receptor -T therapy market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the chimeric antigen receptor -T therapy market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The chimeric antigen receptor -T therapy market includes revenues earned by CAR-T therapy products and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The chimeric antigen receptor -T therapy market research report is one of a series of new reports from The Business Research Company that provides chimeric antigen receptor -T therapy market statistics, including chimeric antigen receptor -T therapy industry global market size, regional shares, competitors with a chimeric antigen receptor -T therapy market share, detailed chimeric antigen receptor -T therapy market segments, market trends and opportunities, and any further data you may need to thrive in the chimeric antigen receptor -T therapy industry. This chimeric antigen receptor -T therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1.   CAR-T Therapy Market Executive Summary

    2.  Table of Contents

    3.   List of Figures

    4.  List of Tables

    5.  Report Structure

    6.  Introduction

    6.1. Segmentation By Geography

    6.2. Segmentation By Target Antigen

    6.3. Segmentation By Application

    7.   CAR-T Therapy Market Characteristics

    7.1. Market Definition

    7.2. Market Segmentation By Target Antigen

    7.2.1. CD19 Therapy

    7.2.2. CD22 Therapy

    7.2.3. BCMA Therapy

    7.2.4. Others

    7.3. Market Segmentation By Application

    7.3.1. Acute Lymphoblastic Leukemia

    7.3.2. Diffuse Large B-Cell Lymphoma

    7.3.3. Follicular Lymphoma

    7.3.4. Chronic Lymphocytic Leukemia

    7.3.5. Multiple Myeloma

    7.3.6. Others

    8.  CAR-T Therapy Market, COVID Impact Analysis

    8.1. Impact On Global CAR-T Therapy

    8.2. Impact On Global CAR-T Therapy Clinical Trials

    8.3. Impact On People Undergoing CAR-T Therapy

    8.4. Impact On Leading Global Oncology Companies

    8.5. Future Outlook

    9.  CAR-T Therapy Market Trends And Strategies

    9.1. Remodeled CAR-T Cell Therapy For Fewer Side Effects

    9.2. Off-The-Shelf Allogeneic CAR-T Therapy For Improved Treatment

    9.3. Next-Generation CAR-T Cells For Treatment Of High-Grade Glioma

    9.4. Machine Learning And Artificial Intelligence To Optimize Future CAR-T Therapy

    9.5. Collaborating With Technology Companies For Advanced Technologies

    9.6. Growing Partnerships For Promoting CAR-T Therapy Market

    10. Global CAR-T Therapy Market Size And Growth

    10.1. Market Size

    10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

    10.2.1. Drivers Of The Market 2015 – 2020

    10.2.2. Restraints On The Market 2015 – 2020

    10.3. Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    10.3.1. Drivers Of The Market 2020 – 2025

    10.3.2. Restraints On The Market 2020 – 2025

    11. Global CAR-T Therapy Market Segmentation

    11.1. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.1.1. CD19

    11.1.2. CD22

    11.1.3. BCMA

    11.2. Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.2.1. Diffuse Large B-Cell Lymphoma

    11.2.2. Acute Lymphoblastic Leukemia

    11.2.3. Follicular Lymphoma

    11.2.4. Multiple Myeloma

    12. CAR-T Therapy Market, Regional And Country Analysis

    12.1. Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    12.2. Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13. Asia-Pacific CAR-T Therapy Market

    13.1. Asia-Pacific CAR-T Therapy Market Overview

    13.1.1. Region Information

    13.1.2. Market Information

    13.1.3. Impact of COVID-19

    13.1.4. Background Information

    13.1.5. Government Initiatives

    13.1.6. Regulations

    13.1.7. Regulatory Bodies

    13.1.8. Major Associations

    13.1.9. Taxes Levied

    13.1.10. Corporate Tax Structure

    13.1.11. Investment

    13.1.12. Major Companies

    13.2. Asia-Pacific CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.3. Asia-Pacific CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.4. Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.5. Asia-Pacific CAR-T Therapy Market: Country Analysis

    13.6. China CAR-T Therapy Market

    13.7. China CAR-T Therapy Market Overview

    13.7.1. Country Information

    13.7.2. Market Information

    13.7.3. Impact of COVID-19

    13.7.4. Background Information

    13.7.5. Government Initiatives

    13.7.6. Regulations

    13.7.7. Regulatory Bodies

    13.7.8. Major Associations

    13.7.9. Taxes Levied

    13.7.10. Corporate Tax Structure

    13.7.11. Investment

    13.7.12. Major Companies

    13.8. China CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.9. China CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.10. China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.11. India CAR-T Therapy Market

    13.12. India CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.13. India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.14. Japan CAR-T Therapy Market

    13.15. Japan CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.16. Japan CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.17. Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.18. Australia CAR-T Therapy Market

    13.19. Australia CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.20. Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.21. Indonesia CAR-T Therapy Market

    13.22. Indonesia CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.23. Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.24. South Korea CAR-T Therapy Market

    13.25. South Korea CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.26. South Korea CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.27. South Korea CAR-T Therapy Market, Segmentation By Application , Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14. Western Europe CAR-T Therapy Market

    14.1. Western Europe CAR-T Therapy Market Overview

    14.1.1. Region Information

    14.1.2. Market Information

    14.1.3. Impact of COVID-19

    14.1.4. Background Information

    14.1.5. Government Initiatives

    14.1.6. Regulations

    14.1.7. Regulatory Bodies

    14.1.8. Major Associations

    14.1.9. Taxes Levied

    14.1.10. Corporate Tax Structure

    14.1.11. Investments

    14.1.12. Major Companies

    14.2. Western Europe CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.3. Western Europe CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.4. Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.5. Western Europe CAR-T Therapy Market: Country Analysis

    14.6. UK CAR-T Therapy Market

    14.7. UK CAR-T Therapy Market Overview

    14.7.1. Country Information

    14.7.2. Market Information

    14.7.3. Impact of COVID-19

    14.7.4. Background Information

    14.7.5. Government Initiatives

    14.7.6. Regulations

    14.7.7. Regulatory Bodies

    14.7.8. Associations

    14.7.9. Taxes Levied

    14.7.10. Corporate Tax Structure

    14.7.11. Investments

    14.7.12. Major Companies

    14.8. UK CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.9. UK CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.10. UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.11. Germany CAR-T Therapy Market

    14.12. Germany CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.13. Germany CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.14. Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.15. France CAR-T Therapy Market

    14.16. France CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.17. France CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.18. France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15. Eastern Europe CAR-T Therapy Market

    15.1. Eastern Europe CAR-T Therapy Market Overview

    15.1.1. Region Information

    15.1.2. Market Information

    15.1.3. Impact of COVID-19

    15.1.4. Background Information

    15.1.5. Government Initiatives

    15.1.6. Regulations

    15.1.7. Regulatory Bodies

    15.1.8. Associations

    15.1.9. Taxes Levied

    15.1.10. Corporate Tax Structure

    15.1.11. Investments

    15.1.12. Major Companies

    15.2. Eastern Europe CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    15.3. Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.4. Eastern Europe CAR-T Therapy Market: Country Analysis

    15.5. Russia CAR-T Therapy Market

    15.6. Russia CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    15.7. Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16. North America CAR-T Therapy Market

    16.1. North America CAR-T Therapy Market Overview

    16.1.1. Region Information

    16.1.2. Market Information

    16.1.3. Impact Of COVID-19

    16.1.4. Background Information

    16.1.5. Government Initiatives

    16.1.6. Regulations

    16.1.7. Regulatory Bodies

    16.1.8. Major Associations

    16.1.9. Taxes Levied

    16.1.10. Corporate Tax Structure

    16.1.11. Investments

    16.1.12. Major Companies

    16.2. North America CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.3. North America CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    16.4. North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.5. North America CAR-T Therapy Market: Country Analysis

    16.6. USA CAR-T Therapy Market

    16.7. USA CAR-T Therapy Market Overview

    16.7.1. Country Information

    16.7.2. Impact Of COVID-19

    16.7.3. Market Information

    16.7.4. Background Information

    16.7.5. Government Initiatives

    16.7.6. Regulations

    16.7.7. Regulatory Bodies

    16.7.8. Major Associations

    16.7.9. Corporate Tax Structure

    16.7.10. Investments

    16.7.11. Major Companies

    16.8. USA CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.9. USA CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    16.10. USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17. South America CAR-T Therapy Market

    17.1. South America CAR-T Therapy Market Overview

    17.1.1. Region Information

    17.1.2. Market Information

    17.1.3. COVID Impact

    17.1.4. Background Information

    17.1.5. Government Initiatives

    17.1.6. Regulations

    17.1.7. Regulatory Bodies

    17.1.8. Major Associations

    17.1.9. Taxes Levied

    17.1.10. Corporate Tax Structure

    17.1.11. Investments

    17.1.12. Major Companies

    17.2. South America CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    17.3. South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.4. South America CAR-T Therapy Market: Country Analysis

    17.5. Brazil CAR-T Therapy Market

    17.6. Brazil CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    17.7. Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    18. Middle East CAR-T Therapy Market

    18.1.Middle East CAR-T Therapy Market Overview

    18.1.1. Region Information

    18.1.2. Market Information

    18.1.3. Impact of COVID-19

    18.1.4. Background Information

    18.1.5. Government Initiatives

    18.1.6. Regulations

    18.1.7. Regulatory Bodies

    18.1.8. Major Associations

    18.1.9. Investments

    18.1.10. Taxes Levied

    18.1.11. Corporate Tax Structure

    18.1.12. Major Companies

    18.2. Middle East CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    18.3.Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19. Africa CAR-T Therapy Market

    19.1.Africa CAR-T Therapy Market Overview

    19.1.1. Region Information

    19.1.2. Market Information

    19.1.3. Impact Of COVID-19

    19.1.4. Background Information

    19.1.5. Government Initiatives

    19.1.6. Regulations

    19.1.7. Regulatory Bodies

    19.1.8. Major Associations

    19.1.9. Investments

    19.1.10. Taxes Levied

    19.1.11. Corporate Tax Structure

    19.1.12. Major Companies

    19.2. Africa CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    19.3.Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    20. Global CAR-T Therapy Market Competitive Landscape

    20.1. Company Profiles

    20.2. Gilead Sciences

    20.2.1. Company Overview

    20.2.2. Products And Services

    20.2.3. Business Strategy

    20.2.4. Financial Overview

    20.3. Novartis AG

    20.3.1. Company Overview

    20.3.2. Products And Services

    20.3.3. Business Strategy

    20.3.4. Financial Overview

    21. CAR-T Therapy Pipeline Analysis

    21.1.Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020

    21.2. CAR T-Cell Therapy, Number Of Active Trials By Cancer Type

    21.3.CAR T-Cell Therapy, Number Of Active Trials By Cancer Type

    21.4. Global CAR-T Cell Therapy By Trial Site

    21.5. Number of Molecules In Cancer Clinical Trails, By Target

    21.6. CAR-T Cell Therapy Pipeline Analysis

    22. Key Mergers And Acquisitions In The CAR-T Therapy Market

    22.1. ResTORbio Merged With Adicet Bio

    22.2. Astellas Pharma Acquired Xyphos Biosciences

    22.3. Bristol Myers Squibb Acquired Celgene Corporation

    22.4. Celgene Acquired Juno Therapeutics

    22.5. Gilead Sciences Acquired Cell Design Labs

    22.6. Gilead Sciences Acquired Kite Pharma

    23. CAR-T Therapy Market Opportunities & Strategies

    23.1.Global CAR-T Therapy Market In 2025 – Countries Offering Most New Opportunities

    23.2. Global CAR-T Therapy Market In 2025 – Segments Offering Most New Opportunities

    23.3.Global CAR-T Therapy Market In 2025 – Growth Strategies

    23.3.1. Market Trend Based Strategies

    23.3.2. Competitor Strategies

    24. CAR-T Therapy Market, Conclusions And Recommendations

    24.1. Conclusions

    24.2. Recommendations

    24.2.1. Product

    24.2.2. Place

    24.2.3. Price

    24.2.4. Promotion

    24.2.5. People

    25. Appendix

    25.1. Market Data Sources

    25.2. Research Methodology

    25.3. Currencies

    25.4. Research Inquiries

    25.5. The Business Research Company

    25.6. Copyright and Disclaimer

List Of Tables

    Table 1: Global CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 2: Global CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 3: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 4: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 5: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 6: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 7: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 8: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 9: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 10: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 11: Asia-Pacific CAR-T Therapy Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 12: Asia-Pacific CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 13: Asia-Pacific Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 14:  Asia Pacific Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 15: Asia-Pacific CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 16: Asia-Pacific CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 17: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 18: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 19: China Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 20: China CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands
  • Table 21: China Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 22:  China Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 23: China CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 24: China CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 25: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 26: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Millio
  • Table 27: India CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 28: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 29: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 30: Japan CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 31: Japan CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 32: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 33: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 34: Australia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 35: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 36: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 37: Indonesia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 38: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 39: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 40: South Korea CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 41: South Korea CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 42: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 43: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 44: Western Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 45: Western Europe CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 46: Western Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 47:  Western Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 48: Corporate Tax Structure In Western Europe Countries, %
  • Table 49: Western Europe CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 50: Western Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 51: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 52: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 53: UK Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 54: UK CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands
  • Table 55: UK Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 56:  UK Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 57: UK CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 58: UK CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 59: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 60: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 61: Germany CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 62: Germany CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 63: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 64: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 65: France CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 66: France CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 67: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 68: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 69: Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 70: Eastern Europe CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 71: Eastern Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 72:  Eastern Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 73: Eastern Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 74: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 75: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 76: Russia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 77: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 78: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 79: North America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 80: North America CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 81: North America Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 82:  North America Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 83: North America CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 84: North America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 85: North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 86: North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 87: USA Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 88: USA CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands
  • Table 89: USA Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 90:  USA Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 91: USA CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 92: USA CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 93: USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 94: USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 95: South America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 96: South America CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 97: South America Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 98:  South America Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 99: South America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 100: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 101: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 102: Brazil CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 103: Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 104: Brazil CAR-T Therapy Market, Segmentation By Application , Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 105: Middle East Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 106: Middle East CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 107: Middle East Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 108:  Middle East Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 109: Middle East CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 110: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 111: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 112: Africa Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 113: Africa CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 114: Africa Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 115:  Africa Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 116: Africa CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 117: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 118: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 119: Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 120: Gilead Sciences – Financial Performance, 2016– 2020, $ Billion
  • Table 121: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
  • Table 122:  Pipeline Analysis Of CAR-T Cell Therapy
  • Table 123: Global CAR-T Therapy Market Size Gain ($ Million), 2020 – 2025, By Country
  • Table 124: Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Target Antigen, 2020 – 2025
  • Table 125: Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
  • Table 126: CAR-T Therapy Market - Data Sources

List Of Figures

    Figure 1: Global CAR-T Therapy Market Segmentation By Target Antigen
  • Figure 2: Global CAR-T Therapy Market Segmentation By Application
  • Figure 3: Global CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 4: Global CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 5: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 6: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 7: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 8: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 9: Asia-Pacific CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 10: Asia-Pacific CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 11: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 12: China CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 13: China CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 14: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 15: India CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 16: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 17: Japan CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 18: Japan CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 19: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 20: Australia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 21: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 22: Indonesia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 23: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 24: South Korea CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 25: South Korea CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 26: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 27: Western Europe CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 28: Western Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 29: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 30: UK CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 31: UK CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 32: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 33: Germany CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 34: Germany CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 35: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 36: France CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 37: France CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 38: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 39: Eastern Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 40: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 41: Russia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 42: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 43: North America CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 44: North America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 45: North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 46: USA CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 47: USA CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 48: USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 49: South America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 50: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 51: Brazil CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 52: Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 53: Middle East CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 54: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 55: Africa CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 56: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 57: Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 58: Gilead Sciences – Financial Performance, 2016 – 2020, $ Billion
  • Figure 59: Novartis AG – Financial Performance, 2016– 2020, $ Billion
  • Figure 60: CAR-T Therapy Market, Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020
  • Figure 61: CAR-T Therapy Market, Number Of Active Trials By Cancer Type
  • Figure 62: CAR-T Therapy Market, Number Of Active Trials By Cancer Type
  • Figure 63: CAR-T Therapy Market, Global CAR-T Cell Therapy By Trial Site
  • Figure 64: CAR-T Therapy Market, Number of Molecules In Cancer Clinical Trials, By Target
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report